TY - JOUR
T1 - CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation
AU - Krajewska, Malgorzata
AU - Dries, Ruben
AU - Grassetti, Andrew V.
AU - Dust, Sofia
AU - Gao, Yang
AU - Huang, Hao
AU - Sharma, Bandana
AU - Day, Daniel S.
AU - Kwiatkowski, Nicholas
AU - Pomaville, Monica
AU - Dodd, Oliver
AU - Chipumuro, Edmond
AU - Zhang, Tinghu
AU - Greenleaf, Arno L.
AU - Yuan, Guo Cheng
AU - Gray, Nathanael S.
AU - Young, Richard A.
AU - Geyer, Matthias
AU - Gerber, Scott A.
AU - George, Rani E.
N1 - Publisher Copyright:
© 2019, The Author(s).
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Cyclin-dependent kinase 12 (CDK12) modulates transcription elongation by phosphorylating the carboxy-terminal domain of RNA polymerase II and selectively affects the expression of genes involved in the DNA damage response (DDR) and mRNA processing. Yet, the mechanisms underlying such selectivity remain unclear. Here we show that CDK12 inhibition in cancer cells lacking CDK12 mutations results in gene length-dependent elongation defects, inducing premature cleavage and polyadenylation (PCPA) and loss of expression of long (>45 kb) genes, a substantial proportion of which participate in the DDR. This early termination phenotype correlates with an increased number of intronic polyadenylation sites, a feature especially prominent among DDR genes. Phosphoproteomic analysis indicated that CDK12 directly phosphorylates pre-mRNA processing factors, including those regulating PCPA. These results support a model in which DDR genes are uniquely susceptible to CDK12 inhibition primarily due to their relatively longer lengths and lower ratios of U1 snRNP binding to intronic polyadenylation sites.
AB - Cyclin-dependent kinase 12 (CDK12) modulates transcription elongation by phosphorylating the carboxy-terminal domain of RNA polymerase II and selectively affects the expression of genes involved in the DNA damage response (DDR) and mRNA processing. Yet, the mechanisms underlying such selectivity remain unclear. Here we show that CDK12 inhibition in cancer cells lacking CDK12 mutations results in gene length-dependent elongation defects, inducing premature cleavage and polyadenylation (PCPA) and loss of expression of long (>45 kb) genes, a substantial proportion of which participate in the DDR. This early termination phenotype correlates with an increased number of intronic polyadenylation sites, a feature especially prominent among DDR genes. Phosphoproteomic analysis indicated that CDK12 directly phosphorylates pre-mRNA processing factors, including those regulating PCPA. These results support a model in which DDR genes are uniquely susceptible to CDK12 inhibition primarily due to their relatively longer lengths and lower ratios of U1 snRNP binding to intronic polyadenylation sites.
UR - https://www.scopus.com/pages/publications/85064432363
U2 - 10.1038/s41467-019-09703-y
DO - 10.1038/s41467-019-09703-y
M3 - Article
C2 - 30988284
AN - SCOPUS:85064432363
SN - 2041-1723
VL - 10
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 1757
ER -